Year |
Citation |
Score |
2023 |
Marie N, Noble F. Oxycodone, an opioid like the others? Frontiers in Psychiatry. 14: 1229439. PMID 38152360 DOI: 10.3389/fpsyt.2023.1229439 |
0.633 |
|
2023 |
Delage C, Morel A, Witt PDE, Jauffret-Roustide M, Bloch V, Noble F, Vorspan F, Marie N. Behavioral sensitization to psychostimulants and opioids: What is known in rodents and what still needs to be explored in humans? Progress in Neuro-Psychopharmacology & Biological Psychiatry. 110824. PMID 37479108 DOI: 10.1016/j.pnpbp.2023.110824 |
0.305 |
|
2023 |
Requana Aradas A, Djaboub Y, McCort-Tranchepain I, Hajasova Z, Clémenceau L, Canestrelli C, Mann A, Schulz S, Delaval A, Acher F, Massotte D, Noble F, Marie N. Activation of the mu-delta opioid receptor heteromers blocks morphine rewarding effects. The International Journal of Neuropsychopharmacology. PMID 37343217 DOI: 10.1093/ijnp/pyad032 |
0.693 |
|
2021 |
Noble F, Marie N. Biased Opioid Ligands: Revolution or Evolution? Frontiers in Pain Research (Lausanne, Switzerland). 2: 722820. PMID 35295469 DOI: 10.3389/fpain.2021.722820 |
0.584 |
|
2020 |
Busserolles J, Soussia IB, Pouchol L, Marie N, Meleine M, Devilliers M, Judon C, Schopp J, Clémenceau L, Poupon L, Chapuy E, Richard S, Noble F, Lesage F, Ducki S, et al. TREK-1 channel activation as a new analgesic strategy devoid of opioid adverse effects. British Journal of Pharmacology. PMID 32851651 DOI: 10.1111/Bph.15243 |
0.696 |
|
2020 |
Camacho E, Marie N, Dupas Q, Martel C, Nowoczyn M, Elie N, Rochais C, Töth G, Allouche S. Impact of T161, Y318 and S363 alanine mutations on regulation of the human delta-opioid receptor (hDOPr) induced by peptidic and alkaloid agonists. Neuropharmacology. 108286. PMID 32841607 DOI: 10.1016/J.Neuropharm.2020.108286 |
0.478 |
|
2019 |
Geoffroy H, Canestrelli C, Marie N, Noble F. Morphine-induced dendritic spine remodeling in rat nucleus accumbens is corticosterone dependent. The International Journal of Neuropsychopharmacology. PMID 30915438 DOI: 10.1093/Ijnp/Pyz014 |
0.523 |
|
2018 |
Noble F, Marie N. Management of Opioid Addiction With Opioid Substitution Treatments: Beyond Methadone and Buprenorphine. Frontiers in Psychiatry. 9: 742. PMID 30713510 DOI: 10.3389/Fpsyt.2018.00742 |
0.696 |
|
2018 |
Marie N, Canestrelli C, Noble F. Role of pharmacokinetic and pharmacodynamic parameters in neuroadaptations induced by drugs of abuse, with a focus on opioids and psychostimulants. Neuroscience and Biobehavioral Reviews. PMID 30340773 DOI: 10.1016/J.Neubiorev.2018.06.006 |
0.483 |
|
2018 |
Hajasova Z, Canestrelli C, Acher F, Noble F, Marie N. Role of mGlu7 receptor in morphine rewarding effects is uncovered by a novel orthosteric agonist. Neuropharmacology. PMID 29307544 DOI: 10.1016/J.Neuropharm.2018.01.002 |
0.602 |
|
2015 |
Posa L, Accarie A, Noble F, Marie N. Methadone Reverses Analgesic Tolerance Induced by Morphine Pretreatment. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). PMID 26390873 DOI: 10.1093/Ijnp/Pyv108 |
0.486 |
|
2015 |
Noble F, Lenoir M, Marie N. The opioid receptors as targets for drug abuse medication. British Journal of Pharmacology. 172: 3964-79. PMID 25988826 DOI: 10.1111/Bph.13190 |
0.671 |
|
2015 |
Allouche S, Le Marec T, Coquerel A, Noble F, Marie N. Striatal dopamine D1 and D2 receptors are differentially regulated following buprenorphine or methadone treatment. Psychopharmacology. 232: 1527-33. PMID 25358852 DOI: 10.1007/S00213-014-3785-X |
0.541 |
|
2014 |
Allouche S, Noble F, Marie N. Opioid receptor desensitization: mechanisms and its link to tolerance. Frontiers in Pharmacology. 5: 280. PMID 25566076 DOI: 10.3389/Fphar.2014.00280 |
0.59 |
|
2014 |
Canestrelli C, Marie N, Noble F. Rewarding or aversive effects of buprenorphine/naloxone combination (Suboxone) depend on conditioning trial duration. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1367-73. PMID 24606726 DOI: 10.1017/S146114571400025X |
0.631 |
|
2014 |
Puig S, Marie N, Benturquia N, Noble F. Influence of cocaine administration patterns on dopamine receptor regulation. Psychopharmacology. 231: 3131-7. PMID 24557089 DOI: 10.1007/S00213-014-3488-3 |
0.343 |
|
2013 |
Nowoczyn M, Marie N, Coulbault L, Hervault M, Davis A, Hanouz JL, Allouche S. Remifentanil produces cross-desensitization and tolerance with morphine on the mu-opioid receptor. Neuropharmacology. 73: 368-79. PMID 23792280 DOI: 10.1016/J.Neuropharm.2013.06.010 |
0.709 |
|
2013 |
Mohammed W, Alhaddad H, Marie N, Tardy F, Lamballais F, Risède P, Noble F, Baud FJ, Mégarbane B. Comparison of tolerance to morphine-induced respiratory and analgesic effects in mice. Toxicology Letters. 217: 251-9. PMID 23296104 DOI: 10.1016/J.Toxlet.2012.12.021 |
0.663 |
|
2013 |
Allouche S, Le Marec T, Noble F, Marie N. Different patterns of administration modulate propensity of methadone and buprenorphine to promote locomotor sensitization in mice. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 40: 286-91. PMID 23103550 DOI: 10.1016/J.Pnpbp.2012.10.013 |
0.555 |
|
2012 |
Marie N, Noble F. [Drug dependence: Progress in neurobiology and perspectives in therapeutics]. Presse MéDicale (Paris, France : 1983). 41: 1259-70. PMID 23040953 DOI: 10.1016/J.Lpm.2012.07.023 |
0.314 |
|
2012 |
Aguila B, Coulbault L, Davis A, Marie N, Hasbi A, Le bras F, Tóth G, Borsodi A, Gurevich VV, Jauzac P, Allouche S. ßarrestin1-biased agonism at human δ-opioid receptor by peptidic and alkaloid ligands. Cellular Signalling. 24: 699-707. PMID 22101011 DOI: 10.1016/J.Cellsig.2011.10.018 |
0.465 |
|
2011 |
Le Marec T, Marie-Claire C, Noble F, Marie N. Chronic and intermittent morphine treatment differently regulates opioid and dopamine systems: a role in locomotor sensitization. Psychopharmacology. 216: 297-303. PMID 21340469 DOI: 10.1007/S00213-011-2223-6 |
0.604 |
|
2010 |
Mégarbane B, Al-Haddad H, Mohammad W, Marie N, Noble F, Baud F. A comparative study in mice of tolerance to morphine analgesic and respiratory effects: Mechanisms and consequences Toxicology Letters. 196: S90-S91. DOI: 10.1016/J.Toxlet.2010.03.329 |
0.564 |
|
2008 |
Marie N, Aguila B, Hasbi A, Davis A, Jauzac P, Allouche S. Different kinases desensitize the human delta-opioid receptor (hDOP-R) in the neuroblastoma cell line SK-N-BE upon peptidic and alkaloid agonists. Cellular Signalling. 20: 1209-20. PMID 18395423 DOI: 10.1016/j.cellsig.2008.02.010 |
0.379 |
|
2006 |
Mégarbane B, Hreiche R, Pirnay S, Marie N, Baud FJ. Does high-dose buprenorphine cause respiratory depression?: possible mechanisms and therapeutic consequences. Toxicological Reviews. 25: 79-85. PMID 16958555 DOI: 10.2165/00139709-200625020-00002 |
0.443 |
|
2006 |
Marie N, Aguila B, Allouche S. Tracking the opioid receptors on the way of desensitization. Cellular Signalling. 18: 1815-33. PMID 16750901 DOI: 10.1016/j.cellsig.2006.03.015 |
0.626 |
|
2006 |
Mégarbane B, Marie N, Pirnay S, Borron SW, Gueye PN, Risède P, Monier C, Noble F, Baud FJ. Buprenorphine is protective against the depressive effects of norbuprenorphine on ventilation. Toxicology and Applied Pharmacology. 212: 256-67. PMID 16169027 DOI: 10.1016/J.Taap.2005.08.002 |
0.337 |
|
2004 |
Lecoq I, Marie N, Jauzac P, Allouche S. Different regulation of human delta-opioid receptors by SNC-80 [(+)-4-[(alphaR)-alpha-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]-N,N-diethylbenzamide] and endogenous enkephalins. The Journal of Pharmacology and Experimental Therapeutics. 310: 666-77. PMID 15102931 DOI: 10.1124/jpet.103.063958 |
0.588 |
|
2003 |
Marie N, Jauzac P, Allouche S. [Opioid tolerance: what if it was just a question of receptor internalization?]. Annales De MéDecine Interne. 154: S73-80. PMID 14760229 |
0.656 |
|
2003 |
Marie N, Landemore G, Debout C, Jauzac P, Allouche S. Pharmacological characterization of AR-M1000390 at human delta opioid receptors. Life Sciences. 73: 1691-704. PMID 12875901 |
0.56 |
|
2003 |
Marie N, Lecoq I, Jauzac P, Allouche S. Differential sorting of human delta-opioid receptors after internalization by peptide and alkaloid agonists. The Journal of Biological Chemistry. 278: 22795-804. PMID 12672796 DOI: 10.1074/jbc.M300084200 |
0.447 |
|
1999 |
Allouche S, Roussel M, Marie N, Jauzac P. Differential desensitization of human delta-opioid receptors by peptide and alkaloid agonists. European Journal of Pharmacology. 371: 235-40. PMID 10357261 |
0.537 |
|
Show low-probability matches. |